Dr. Martens plc (LON:DOCS - Get Free Report) shares traded up 25.8% during trading on Thursday . The company traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). 8,364,149 shares were traded during trading, an increase of 271% from the average session volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).
Analysts Set New Price Targets
Separately, Royal Bank of Canada cut their target price on shares of Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a "sector perform" rating for the company in a research note on Monday, May 19th.
Check Out Our Latest Analysis on Dr. Martens
Dr. Martens Price Performance
The company has a 50-day moving average of GBX 54.24 and a two-hundred day moving average of GBX 62.52. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. The stock has a market capitalization of £731.96 million, a PE ratio of 10.69, a P/E/G ratio of 6.40 and a beta of 0.11.
Dr. Martens (LON:DOCS - Get Free Report) last released its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Sell-side analysts predict that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.
Dr. Martens Cuts Dividend
The company also recently announced a dividend, which was paid on Tuesday, April 8th. Investors of record on Thursday, March 6th were given a GBX 0.85 ($0.01) dividend. This represents a dividend yield of 1.47%. The ex-dividend date of this dividend was Thursday, March 6th. Dr. Martens's dividend payout ratio (DPR) is currently 42.53%.
Insider Buying and Selling at Dr. Martens
In related news, insider Giles Wilson bought 32,640 shares of the stock in a transaction dated Tuesday, March 25th. The stock was acquired at an average price of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,934.82). Over the last 90 days, insiders bought 33,206 shares of company stock valued at $1,792,771. Company insiders own 4.36% of the company's stock.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
